Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports

被引：18
作者：
De Simone, Clara [1 ]
Perino, Francesca [1 ]
Caldarola, Giacomo [1 ]
D'Agostino, Magda [1 ]
Peris, Ketty [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Dermatol, Rome, Italy
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2016年 / 44卷
关键词：
Antitumour necrosis factor- agents; comorbidities; etanercept; psoriasis; psoriatic arthritis; HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-TRANSPLANT; HIV; THERAPY; PATHOGENESIS; ARTHRITIS;
D O I：
10.1177/0300060515593250
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Tumour necrosis factor (TNF)- blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF- agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF- agent, without notable side-effects.
引用
收藏
页码：67 / 71
页数：5
相关论文
共 50 条
  • [31] Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients
    Jin, Waishu
    Zhang, Shuqing
    Duan, Yanjuan
    DERMATOLOGY, 2019, 235 (01) : 55 - 64
  • [32] Refractory psoriasis treatment with etanercept
    Santos, LM
    Martinez-Menchón, T
    Carazo, JLS
    Pérez-Ferriols, A
    Navarro, CJS
    Baixauli, JMF
    MEDICINA CLINICA, 2005, 125 (10): : 371 - 373
  • [33] Etanercept: an overview of its role in the treatment of psoriasis
    Galindo, Malini Patel
    Bartlett, Brenda L.
    Gewirtzman, Aron
    Mendoza, Natalia
    Tremaine, Anne Marie
    Tyring, Stephen K.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (03) : 305 - 310
  • [34] Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment
    Puig, Lluis
    Strohal, Robert
    Fuiman, Joanne
    Pedersen, Ronald
    Szumski, Annette
    Koenig, Andrew S.
    Robertson, Deborah
    Drexel, Heinz
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (06) : 470 - 481
  • [35] Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence
    Foley, P. A.
    Quirk, C.
    Sullivan, J. R.
    Dolianitis, C.
    Hack, S. P.
    Thirunavukkarasu, K.
    Cooper, A. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (10) : 1135 - 1143
  • [36] Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanercept
    Yang, A.
    Xin, X.
    Yang, W.
    Li, M.
    Yang, W.
    Li, L.
    Liu, X.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (05): : 363 - 371
  • [37] AdalimumabParadoxical worsening of psoriasis: 4 case reports
    Reactions Weekly, 2011, 1347 (1) : 7 - 7
  • [38] Leukemic Phase of Follicular Lymphoma after Treatment with Etanercept in a Patient with Psoriasis
    Siddhartha Ganguly
    American Journal of Clinical Dermatology, 2009, 10 : 125 - 126
  • [39] Multiple lentigines in psoriasis patients treated with etanercept
    Francisco Manuel Almazán-Fernaández
    Pablo Fernández-Crehuet
    European Journal of Dermatology, 2015, 25 : 354 - 356
  • [40] Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
    Kivelevitch, Dario
    Mansouri, Bobbak
    Menter, Alan
    BIOLOGICS-TARGETS & THERAPY, 2014, 8 : 169 - 182
12345